Amcor Limited (ASX: AMC) – Leading consumer packaging firms Amcor and Bemis decide to undergo merger


Australia’s packaging company, Amcor Limited (ASX: AMC), is acquiring NYSE listed Bemis for all-stock transaction. With the fixed stock exchange ratio of 5.1 Amcor share for each Bemis share, Amcor shareholders cling to 71% of ownership over 29% of Bemis holdings in newly created “New Amcor.”

Early this day, the boards of leading consumer packaging companies, Amcor and Bemis, announced their merger through newly formed “New Amcor”, incorporated in Jersey. The New Amcor will have a primary listing on New York Stock Exchange and an ASX listing via CHESS Depository Interest.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The key selling point of the deal lies in the cost synergy potential of approximately US$ 180 million. This merger transaction represents the potential to grow through delivery of cost synergies resulting to give double digit returns to its shareholders.

The purchase consideration for the transaction amounts to premium price of US$75.75 per Bemis share, based on Amcor’s A$15.28 per share.

Amcor’s management continues to lead the newly incorporated New Amcor. While Graeme Liebelt continues to chair, 8 current Amcor directors and 3 current Bemis directors are reported to be on board with Ron Delia serving to be the only executive director of the company.

Following to Amcor-Bemis merger deal announcement, AMC shares fell by 5.8% to $14.390.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report